Efficacy of Oxcarbazepine for Sleep-Related Leg Cramps: A Retrospective Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Sleep-related leg cramps (SRLC) are common among older people. Severe clinical symptoms of SRLC usually cause great discomfort to patients. To date, many treatment drugs have been tried; however, there are currently no drugs approved for treating this condition. We aimed to assess the efficacy of a new drug, oxcarbazepine (OXC), in the treatment of SRLC.Methods: We retrospectively analyzed clinical outcomes following OXC administration. A daily dose of 150 mg OXC was prescribed to control nocturnal leg cramps. Clinical outcomes were measured using the Clinical Global Impression Scale to confirm the effectiveness of OXC.Results: A total of 88.9% (16/18) of patients clinically improved four weeks after OXC prescription, and 94% (15/16) of patients continued to improve at the last follow-up (3–6 months). None of the patients complained of side effects related to 150 mg OXC.Conclusions: OXC may be a new medical option for treatment of SRLC.
Abstract
Objectives: Sleep-related leg cramps (SRLC) are common among older people. Severe clinical symptoms of SRLC usually cause great discomfort to patients. To date, many treatment drugs have been tried; however, there are currently no drugs approved for treating this condition. We aimed to assess the efficacy of a new drug, oxcarbazepine (OXC), in the treatment of SRLC.Methods: We retrospectively analyzed clinical outcomes following OXC administration. A daily dose of 150 mg OXC was prescribed to control nocturnal leg cramps. Clinical outcomes were measured using the Clinical Global Impression Scale to confirm the effectiveness of OXC.Results: A total of 88.9% (16/18) of patients clinically improved four weeks after OXC prescription, and 94% (15/16) of patients continued to improve at the last follow-up (3–6 months). None of the patients complained of side effects related to 150 mg OXC.Conclusions: OXC may be a new medical option for treatment of SRLC.
참고문헌 (18)
- American Academy of Sleep Medicine, "The international classification of sleep disorders", American Academy of Sleep Medicine, ~ (2014)
- Renee S. Monderer, "Nocturnal Leg Cramps", Current Neurology and Neuroscience Reports, 10(1), pp.53~59 (2010), Springer Science and Business Media LLC[DOI]
- Michael A. Grandner, "Nocturnal leg cramps: Prevalence and associations with demographics, sleep disturbance symptoms, medical conditions, and cardiometabolic risk factors", PLOS ONE, 12(6), pp.e0178465~ (2017), Public Library of Science (PLoS)[DOI]
- Man-Son-Hing M, "Quinine for nocturnal leg cramps: a meta-analysis including unpublished data", J Gen Intern Med, 13, pp.600~606 (1998)[DOI]
- Noga Roguin Maor, "Effect of Magnesium Oxide Supplementation on Nocturnal Leg Cramps", JAMA Internal Medicine, 177(5), pp.617~623 (2017), American Medical Association (AMA)[DOI]
- Chan P, "Randomized, double-blind, placebo-controlled study of the safety and efficacy of vitamin B complex in the treatment of nocturnal leg cramps in elderly patients with hypertension", J Clin Pharmacol, 38, pp.1151~1154 (1998)[DOI]
- J. B. Young, "Naftidrofuryl treatment for rest cramp", Postgraduate Medical Journal, 69(814), pp.624~626 (1993), BMJ[DOI]
- Neyton Baltodano, "Verapamil vs Quinine in Recumbent Nocturnal Leg Cramps in the Elderly", Archives of Internal Medicine, 148(9), pp.1969~1970 (1988), American Medical Association (AMA)[DOI]
- H. D. Katzberg, "Assessment: Symptomatic treatment for muscle cramps (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology", Neurology, 74(8), pp.691~696 (2010), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Busner J, "The clinical global impressions scale: applying a research tool in clinical practice", Psychiatry(Edgmont), 4, pp.28~37 (2007)
- Richard K. Bogan, "Ropinirole in the Treatment of Patients With Restless Legs Syndrome: A US-Based Randomized, Double-Blind, Placebo-Controlled Clinical Trial", Mayo Clinic Proceedings, 81(1), pp.17~27 (2006), Elsevier BV[DOI]
- M. Swash, "Muscular cramp: causes and management", European Journal of Neurology, 26(2), pp.214~221 (2019), Wiley[DOI]
- Hans D. Katzberg, "Neurogenic muscle cramps", Journal of Neurology, 262(8), pp.1814~1821 (2015), Springer Science and Business Media LLC[DOI]
- M. Man-Son-Hing, "Meta-analysis of efficacy of quinine for treatment of nocturnal leg cramps in elderly people", BMJ, 310(6971), pp.13~17 (1995), BMJ[DOI]
- Mariano Serrao, "Gabapentin Treatment for Muscle Cramps: An Open-Label Trial", Clinical Neuropharmacology, 23(1), pp.45~49 (2000), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Bedlack RS, "Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease", Amyotroph Lateral Scler, 10, pp.210~215 (2009)[DOI]
- A. J. Tahmoush, "Cramp,fasciculation syndrome: A treatable hyperexcitable peripheral nerve disorder", Neurology, 41(7), pp.1021~1021 (1991), Ovid Technologies (Wolters Kluwer Health)[DOI]
- 김경민, "야간근육경련의 페니토인 치료효과: 예비연구", 대한신경과학회지, 32(4), pp.254~258 (2014), 대한신경과학회